The publication of the first three EU Joint Clinical Assessments (JCAs) provides the first opportuni...
Executive Summary Rare disease assessments rely on specialist clinical and patient expertise to inte...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.